LAPTM5 and renal cell carcinoma: Mechanistic studies using IP-MS in murine and human RCC cell lines (Renca and 786-O) uncovered aLAPTM5 binding protein WWP2 and established the regulatory role of LAPTM5/WWP2 in the ubiquitination and lysosomal degradation of BMPR1A.